For patients with bronchial asthma, drug treatment is generally adopted, and surgery is possible when necessary. Specific treatment options should be selected according to the cause of the disease and individual physical condition, there is no so-called “best” treatment program, please follow the doctor’s instructions standardized treatment. Pharmacological treatment: In acute asthma attacks, short-acting β2 agonists such as salbutamol and terbutaline, intravenous glucocorticosteroids such as methylprednisolone, theophyllines such as aminophylline, and short-acting anticholinergic drugs such as ipratropium bromide are used, and when the effect is not good, mechanical ventilation is given. In chronic remission, inhaled glucocorticosteroids such as budesonide, long-acting β2 agonists such as salmeterol and formoterol, long-acting anticholinergic drugs such as tiotropium bromide, leukotriene modulators such as montelukast sodium, and small doses of theophyllines can be used. In patients with severe or refractory asthma that cannot be controlled despite the use of the maximum dose of medication and a combination of multiple medications, bronchial thermoplasty may be performed. This procedure can significantly reduce acute asthma exacerbations and improve the level of asthma control. The occurrence of bronchial asthma is related to environmental factors, genetic factors, etc. Due to the different physical conditions of the patients and the different stages of the disease, the treatments are correspondingly different and should be standardized under the guidance of the doctor.